Cargando…

MicroRNA-154: A Novel Candidate for Diagnosis and Therapy of Human Cancers

MicroRNAs (miRNAs) are endogenous, non-coding, single-stranded, tiny RNAs with 21–23 nucleotides that regulate several biological functions through binding to target mRNAs and modulating gene expression at post-transcriptional levels. Recent studies have described crucial roles for miRNAs in pathoph...

Descripción completa

Detalles Bibliográficos
Autores principales: Nazarizadeh, Ali, Mohammadi, Forogh, Alian, Fatemeh, Faraji, Parisa, Nourbakhsh, Mitra, Alizadeh-Fanalou, Shahin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7354082/
https://www.ncbi.nlm.nih.gov/pubmed/32753896
http://dx.doi.org/10.2147/OTT.S249268
_version_ 1783558010383106048
author Nazarizadeh, Ali
Mohammadi, Forogh
Alian, Fatemeh
Faraji, Parisa
Nourbakhsh, Mitra
Alizadeh-Fanalou, Shahin
author_facet Nazarizadeh, Ali
Mohammadi, Forogh
Alian, Fatemeh
Faraji, Parisa
Nourbakhsh, Mitra
Alizadeh-Fanalou, Shahin
author_sort Nazarizadeh, Ali
collection PubMed
description MicroRNAs (miRNAs) are endogenous, non-coding, single-stranded, tiny RNAs with 21–23 nucleotides that regulate several biological functions through binding to target mRNAs and modulating gene expression at post-transcriptional levels. Recent studies have described crucial roles for miRNAs in pathophysiology of numerous human cancers. They can act as an oncogene and promote cancer or as a tumor suppressor and alleviate the disease. Recently discovered microRNA-154 (miR-154) has been proposed to be involved in multiple physiological and pathological processes including cancer. With this aspect, aberrant expression of miR-154 has been demonstrated in variety of human malignancies, suggesting an important role for miR-154 in tumorigenesis. To be specific, it is considered as a tumor suppressor miRNA and exerts its beneficial effects by targeting several genes. This review systematically summarizes the recent advances done on the role of miR-154 in different cancers and discusses its potential prognostic, diagnostic and therapeutic values.
format Online
Article
Text
id pubmed-7354082
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-73540822020-08-03 MicroRNA-154: A Novel Candidate for Diagnosis and Therapy of Human Cancers Nazarizadeh, Ali Mohammadi, Forogh Alian, Fatemeh Faraji, Parisa Nourbakhsh, Mitra Alizadeh-Fanalou, Shahin Onco Targets Ther Review MicroRNAs (miRNAs) are endogenous, non-coding, single-stranded, tiny RNAs with 21–23 nucleotides that regulate several biological functions through binding to target mRNAs and modulating gene expression at post-transcriptional levels. Recent studies have described crucial roles for miRNAs in pathophysiology of numerous human cancers. They can act as an oncogene and promote cancer or as a tumor suppressor and alleviate the disease. Recently discovered microRNA-154 (miR-154) has been proposed to be involved in multiple physiological and pathological processes including cancer. With this aspect, aberrant expression of miR-154 has been demonstrated in variety of human malignancies, suggesting an important role for miR-154 in tumorigenesis. To be specific, it is considered as a tumor suppressor miRNA and exerts its beneficial effects by targeting several genes. This review systematically summarizes the recent advances done on the role of miR-154 in different cancers and discusses its potential prognostic, diagnostic and therapeutic values. Dove 2020-07-07 /pmc/articles/PMC7354082/ /pubmed/32753896 http://dx.doi.org/10.2147/OTT.S249268 Text en © 2020 Nazarizadeh et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Review
Nazarizadeh, Ali
Mohammadi, Forogh
Alian, Fatemeh
Faraji, Parisa
Nourbakhsh, Mitra
Alizadeh-Fanalou, Shahin
MicroRNA-154: A Novel Candidate for Diagnosis and Therapy of Human Cancers
title MicroRNA-154: A Novel Candidate for Diagnosis and Therapy of Human Cancers
title_full MicroRNA-154: A Novel Candidate for Diagnosis and Therapy of Human Cancers
title_fullStr MicroRNA-154: A Novel Candidate for Diagnosis and Therapy of Human Cancers
title_full_unstemmed MicroRNA-154: A Novel Candidate for Diagnosis and Therapy of Human Cancers
title_short MicroRNA-154: A Novel Candidate for Diagnosis and Therapy of Human Cancers
title_sort microrna-154: a novel candidate for diagnosis and therapy of human cancers
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7354082/
https://www.ncbi.nlm.nih.gov/pubmed/32753896
http://dx.doi.org/10.2147/OTT.S249268
work_keys_str_mv AT nazarizadehali microrna154anovelcandidatefordiagnosisandtherapyofhumancancers
AT mohammadiforogh microrna154anovelcandidatefordiagnosisandtherapyofhumancancers
AT alianfatemeh microrna154anovelcandidatefordiagnosisandtherapyofhumancancers
AT farajiparisa microrna154anovelcandidatefordiagnosisandtherapyofhumancancers
AT nourbakhshmitra microrna154anovelcandidatefordiagnosisandtherapyofhumancancers
AT alizadehfanaloushahin microrna154anovelcandidatefordiagnosisandtherapyofhumancancers